Prophezeiung die Absicht Unerwartet teva rituxan biosimilar Kämpfer Rand Assoziieren
Biosimilars encircle Rituxan, US debates innovator exclusivity | Nature Biotechnology
Teva: Biosimilars In The US Will Become Like Complex Generics :: Generics Bulletin
Teva teams up on biosims with Celltrion three years after its Lonza JV divorce | Fierce Biotech
Drug Channels: The Booming Biosimilar Market of 2020
Teva and Celltrion Announce the Availability of TRUXIMA® (rituximab-abbs) Injection, the First Biosimilar to Rituxan® (rituximab) in the United States | Business Wire
Teva, Celltrion get FDA nod for biosimilar to Roche's cancer drug Rituxan
Roche faces prospect of second Rituxan biosimilar in US - PMLiVE
Teva's Rituxan Biosimilar Gets FDA Nod in Non-Hodgkin Lymphoma
Top 25 Biosimilar Drug Manufacturers 2019 - Visiongain Research Report